menu search

Replimune presents rp1 data from the ignyte anti-pd1 failed melanoma cohort and rp2 data in uveal melanoma at the 2023 american society of clinical oncology (asco) annual meeting

Updated data from ongoing IGNYTE anti-PD1 failed melanoma cohort shows RP1 combined with nivolumab continues to demonstrate deep and durable responses...

June 3, 2023, 6:15 pm

Allogene therapeutics presents updated allo-501/501a phase 1 data in large b cell lymphoma at the american society of clinical oncology (asco) annual meeting

Long Term Follow Up Data from Phase 1 ALPHA/ALPHA2 Trials Demonstrate Potential of Allogeneic CD19 CAR T to Generate Durable Complete Responses Simila...

June 3, 2023, 1:00 pm

The manitowoc company to present and host 1x1 investor meetings at the 13th annual east coast ideas conference on thursday, june 22, 2023

MILWAUKEE--(BUSINESS WIRE)--The Manitowoc Company, Inc. (NYSE: MTW) announced today that Executive Vice President and Chief Financial Officer, Brian P...

June 2, 2023, 5:27 pm

Bristol myers squibb ceo on cancer drug pipeline

Dr. Giovanni Caforio, Bristol Myers Squibb CEO, joins 'The Exchange' to discuss the asco Annual Cancer ...

June 2, 2023, 2:25 pm

Autolus therapeutics presents positive results from pivotal phase 2 felix study in adult r/r b-all at asco

76% of patients treated with obe-cel in the FELIX study achieved a response (CR/CRi), primary endpoint has been met based on previously communicated i...

June 2, 2023, 11:00 am

Decibel therapeutics to present db-020 phase 1b clinical trial data at the american society of clinical oncology (asco) 2023 annual meeting

Data from interim analysis support DB-020 as a potential therapy to protect patients against irreversible hearing loss associated with cisplatin chemo...

June 1, 2023, 8:30 pm

Gilead: pharma play worth watching on multitude of asco data readouts

Gilead Sciences, Inc. is expected to offer 30 Abstract Presentations at the asco 2023 medical meeting t...

May 31, 2023, 7:11 pm

Amgen inc. (amgn) 4th annual oncology innovation summit: insights for asco & eha (transcript)

Amgen Inc. (NASDAQ:AMGN ) 4th Annual Oncology Innovation Summit: Insights for asco & EHA May 31, 2023 1...

May 31, 2023, 2:20 pm

Illumina (ilmn) to present real-world cgp data at asco meet '23

At the asco meeting, Illumina (ILMN) is set to showcase data that highlights better outcomes for cancer...

May 31, 2023, 10:30 am

Russia's novak says to discuss oil market situation with oil companies on 30 may

Novak endured a bit of a fiasco last week as seen here, but the latest headline above shouldn't be anyt...

May 30, 2023, 7:39 am

Installed building products: good long-term prospects

The weakening single-family residential end market is a near-term headwind. However, there is light at the end of the tunnel with the Fed becoming les...

May 28, 2023, 5:34 am

Molecular templates to present on phase i dose escalation study of mt-6402 at the 2023 american society of clinical oncology (asco) annual meeting

AUSTIN, Texas, May 26, 2023 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage ...

May 26, 2023, 9:10 pm

Molecular templates to present on phase i dose escalation study of mt-6402 at the 2023 american society of clinical oncology (asco) annual meeting

AUSTIN, Texas, May 26, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage ...

May 26, 2023, 5:10 pm

Genprex says positive data from acclaim-1 clinical trial to be published at 2023 asco meeting

Genprex Inc. (NASDAQ:GNPX) said positive data from the Phase 1 portion of its Acclaim-1 clinical trial evaluating REQORSA Immunogene Therapy in combin...

May 26, 2023, 8:06 am

Roche to present new data in blood cancers and solid tumours from its broad portfolio at asco 2023

Basel, 26 May 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) will be presenting new data on six approved and investigational medicines across ten cancer ty...

May 26, 2023, 1:00 am

Correction — day one announces tovorafenib (day101) data and additional abstracts to be presented at the 2023 american society of clinical oncology (asco) annual meeting

BRISBANE, Calif., May 25, 2023 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Day One Biopharmaceuticals, Inc. (Nas...

May 26, 2023, 12:30 am


Search within

Pages Search Results: